MDL | - |
---|---|
Molecular Weight | 561.07 |
Molecular Formula | C34H29ClN4O2 |
SMILES | O=C1N(C2=CC=CC=C2)N(C)C(C3=CC=CC=C3)=C1C(C4=CC=C(C)C(C5=CC=C6N=C(C)C=CC6=C5)=C4N)=O.[H]Cl |
IC50: 6 nM (PERK) [1]
AMG PERK 44 has an IC 50 of 84 nM for cell pPERK [1] .
MCE has not independently confirmed the accuracy of these methods. They are for reference only.
AMG PERK 44 (orally; 3-100 mg/kg) robustly inhibits PERK autophosphorylation in this assay (ED
50
=3 mg/kg; ED
90
=60 mg/kg at the 4 hours time point), and >50% target coverage is maintained for 24 h in a time course PD assay when dosed at 100 mg/kg po
[1]
.
AMG PERK 44 (iv; 1 mg/kg) has a CL of 1.6 L/h•kg, a V
ss
of 3.6 L/kg and MRT of 2.3 hours in Sprague-Dawley rats and male CD-1 mice
[1]
.
MCE has not independently confirmed the accuracy of these methods. They are for reference only.
Animal Model: | Four- to six-week old naive athymic nude mice [1] |
Dosage: | 3, 10, 30, 100 mg/kg |
Administration: | Orally |
Result: | Robustly inhibited PERK autophosphorylation in this assay (ED 50 =3 mg/kg; ED 90 =60 mg/kg at the 4 hours time point). |
Animal Model: | Sprague-Dawley rats and male CD-1 mice [1] |
Dosage: | 1 mg/kg (Pharmacokinetic Analysis) |
Administration: | Iv |
Result: | Had a CL of 1.6 L/h•kg, a V ss of 3.6 L/kg and a MRT of 2.3 hours. |
Solid
Room temperature in continental US; may vary elsewhere.
-20°C, sealed storage, away from moisture
* In solvent : -80°C, 6 months; -20°C, 1 month (sealed storage, away from moisture)
DMSO : 25 mg/mL ( 44.56 mM ; Need ultrasonic)
Concentration Solvent Mass | 1 mg | 5 mg | 10 mg |
---|
1 mM | 1.7823 mL | 8.9115 mL | 17.8231 mL |
5 mM | 0.3565 mL | 1.7823 mL | 3.5646 mL |
10 mM | 0.1782 mL | 0.8912 mL | 1.7823 mL |